BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 14636726)

  • 1. Extracellular and intracellular barriers in non-viral gene delivery.
    Ruponen M; Honkakoski P; Rönkkö S; Pelkonen J; Tammi M; Urtti A
    J Control Release; 2003 Dec; 93(2):213-7. PubMed ID: 14636726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of polymeric and liposomal gene delivery systems with extracellular glycosaminoglycans: physicochemical and transfection studies.
    Ruponen M; Ylä-Herttuala S; Urtti A
    Biochim Biophys Acta; 1999 Jan; 1415(2):331-41. PubMed ID: 9889391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell-surface glycosaminoglycans inhibit cation-mediated gene transfer.
    Ruponen M; Honkakoski P; Tammi M; Urtti A
    J Gene Med; 2004 Apr; 6(4):405-14. PubMed ID: 15079815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between DNA-cationic liposome complexes and erythrocytes is an important factor in systemic gene transfer via the intravenous route in mice: the role of the neutral helper lipid.
    Sakurai F; Nishioka T; Saito H; Baba T; Okuda A; Matsumoto O; Taga T; Yamashita F; Takakura Y; Hashida M
    Gene Ther; 2001 May; 8(9):677-86. PubMed ID: 11406762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physico-chemical characterisation and transfection efficiency of lipid-based gene delivery complexes.
    Birchall JC; Kellaway IW; Mills SN
    Int J Pharm; 1999 Jun; 183(2):195-207. PubMed ID: 10361170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extracellular glycosaminoglycans modify cellular trafficking of lipoplexes and polyplexes.
    Ruponen M; Rönkkö S; Honkakoski P; Pelkonen J; Tammi M; Urtti A
    J Biol Chem; 2001 Sep; 276(36):33875-80. PubMed ID: 11390375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A lipid carrier with a membrane active component and a small complex size are required for efficient cellular delivery of anti-sense phosphorothioate oligonucleotides.
    Jääskeläinen I; Peltola S; Honkakoski P; Mönkkönen J; Urtti A
    Eur J Pharm Sci; 2000 May; 10(3):187-93. PubMed ID: 10767596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of size, lipid composition and bilayer fluidity of cationic liposomes on the transfection efficiency of nanolipoplexes.
    Ramezani M; Khoshhamdam M; Dehshahri A; Malaekeh-Nikouei B
    Colloids Surf B Biointerfaces; 2009 Aug; 72(1):1-5. PubMed ID: 19395245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrostatic parameters of cationic liposomes commonly used for gene delivery as determined by 4-heptadecyl-7-hydroxycoumarin.
    Zuidam NJ; Barenholz Y
    Biochim Biophys Acta; 1997 Oct; 1329(2):211-22. PubMed ID: 9371413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery.
    Plank C; Mechtler K; Szoka FC; Wagner E
    Hum Gene Ther; 1996 Aug; 7(12):1437-46. PubMed ID: 8844203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compositional effects of cationic lipid/DNA delivery systems on transgene expression in cell culture.
    Wiethoff CM; Koe JG; Koe GS; Middaugh CR
    J Pharm Sci; 2004 Jan; 93(1):108-23. PubMed ID: 14648641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. siRNA delivery to lung-metastasized tumor by systemic injection with cationic liposomes.
    Hattori Y; Nakamura A; Arai S; Kawano K; Maitani Y; Yonemochi E
    J Liposome Res; 2015; 25(4):279-86. PubMed ID: 25543847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DOTAP cationic liposomes prefer relaxed over supercoiled plasmids.
    Even-Chen S; Barenholz Y
    Biochim Biophys Acta; 2000 Dec; 1509(1-2):176-88. PubMed ID: 11118529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycosaminoglycan-resistant and pH-sensitive lipid-coated DNA complexes produced by detergent removal method.
    Lehtinen J; Hyvönen Z; Subrizi A; Bunjes H; Urtti A
    J Control Release; 2008 Oct; 131(2):145-9. PubMed ID: 18691618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary surfactant inhibits cationic liposome-mediated gene delivery to respiratory epithelial cells in vitro.
    Duncan JE; Whitsett JA; Horowitz AD
    Hum Gene Ther; 1997 Mar; 8(4):431-8. PubMed ID: 9054518
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low toxicity of cationic lipid-based emulsion for gene transfer.
    Choi WJ; Kim JK; Choi SH; Park JS; Ahn WS; Kim CK
    Biomaterials; 2004 Dec; 25(27):5893-903. PubMed ID: 15172502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Progress in the development of lipopolyplexes as efficient non-viral gene delivery systems.
    Rezaee M; Oskuee RK; Nassirli H; Malaekeh-Nikouei B
    J Control Release; 2016 Aug; 236():1-14. PubMed ID: 27317365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using disaccharides to enhance in vitro and in vivo transgene expression mediated by a lipid-based gene delivery system.
    Tseng WC; Tang CH; Fang TY; Su LY
    J Gene Med; 2007 Aug; 9(8):659-67. PubMed ID: 17611953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic effect of polyethylenimine and cationic liposomes in nucleic acid delivery to human cancer cells.
    Lee CH; Ni YH; Chen CC; Chou C; Chang FH
    Biochim Biophys Acta; 2003 Apr; 1611(1-2):55-62. PubMed ID: 12659945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cationic compounds used in lipoplexes and polyplexes for gene delivery.
    Zhang S; Xu Y; Wang B; Qiao W; Liu D; Li Z
    J Control Release; 2004 Nov; 100(2):165-80. PubMed ID: 15544865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.